Pharmaceuticals

Dr. Reddy’s Announces the Launch of Metoprolol Succinate ER (Extended-Release) Tablets

11 Sep 2012

USFDA approves Aurobindo Pharma's hypertension drugs

07 Sep 2012

Hiring freeze in pharma industry expected: survey

06 Sep 2012

Canada’s Valeant to acquire Medicis Pharmaceutical for $2.6 bn

04 Sep 2012

German maker of thalidomide apologises, after 50 years

01 Sep 2012

Medical technology firm ConvaTec to buy 180 Medical Holdings for $321 mn

01 Sep 2012

J & J to pay $181 million to settle Risperdal's illegal marketing claims

31 Aug 2012

Genmab in $1.1-bn onco drug licencing deal with Johnson & Johnson

30 Aug 2012

Orchid sells API, R&D unit to Hospira for Rs1,113 crore to reduce debt

30 Aug 2012

The businesses sold accounted for around 23 per cent of the total sales of the company last year

Sun Pharma gets partial US FDA clearance to resume US operations

29 Aug 2012

Aetna to buy Coventry Healthcare in $5.7-bn deal

22 Aug 2012

US health insurer Aetna Inc, on Monday signed a deal to buy rival Coventry Healthcare Inc for $5.7 billion in order to expand its Medicaid business

Wockhardt to launch generic hypertension drug in US

21 Aug 2012

GSK to sell Australian generic portfolio to Aspen Pharma

16 Aug 2012

Grand Slam Asset Management rejects Sun Pharma’s sweetened offer for Taro

14 Aug 2012

Pfizer files IPO for animal health unit Zoetis Inc

14 Aug 2012

Pfizer yesterday filed for an initial public offering (IPO) for its animal health unit Zoetis Inc, as part of its plan to pay off debt and focus on its core busines

Sun Pharma to buy out Israel’s Taro for $571 million

13 Aug 2012

Taro Pharmaceutical Industries has agreed to a new offer of Sun Pharma, which already owns 66.3 per cent of Taro, to pay $39.50 per share for the remaining stake held by Taro’s minority shareholders

Sun Pharma to spin off domestic formulations business into Sun Resins & Polymers

11 Aug 2012

AstraZeneca to pay Bristol-Myers Squibb $135 mn more for Amylin drug rights

10 Aug 2012

AstraZeneca will pay the $135 million to Bristol-Myers Squibb after the anti-trust and other competition regulators approve the acquisition of Amylin

Warner Chilcott scraps sale plans; to pay $1 billion dividend

08 Aug 2012

Pfizer to pay $60 mn to settle US bribery charges

08 Aug 2012

BC Partners to buy German generic drugs maker Aenova for $618 mn

07 Aug 2012

Teva Pharmaceutical under US scanner for bribing officials in Latin America

06 Aug 2012

Sun Pharmaceuticals eyes German generic-drug maker Stada: report

03 Aug 2012

Ranbaxy in licensing pact with Gilead for HIV drug

03 Aug 2012

European regulator charges Teva, Lupin and Unichem for blocking perindopril

30 Jul 2012